Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.

PLoS One 2014 16;9(7):e102397. Epub 2014 Jul 16.

Experimental Neurology, Department of Neurology, Philipps-University, Marburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology, Technical University, Munich, Germany.

With the aim to develop beneficial tracers for cerebral tumors, we tested two novel 5-iodo-2'-deoxyuridine (IUdR) derivatives, diesterified at the deoxyribose residue. The substances were designed to enhance the uptake into brain tumor tissue and to prolong the availability in the organism. We synthesized carrier added 5-[125I]iodo-3',5'-di-O-acetyl-2'-deoxyuridine (Ac2[125I]IUdR), 5-[125I]iodo-3',5'-di-O-pivaloyl-2'-deoxyuridine (Piv2[125I]IUdR) and their respective precursor molecules for the first time. HPLC was used for purification and to determine the specific activities. The iodonucleoside tracer were tested for their stability against human thymidine phosphorylase. DNA integration of each tracer was determined in 2 glioma cell lines (Gl261, CRL2397) and in PC12 cells in vitro. In mice, we measured the relative biodistribution and the tracer uptake in grafted brain tumors. Ac2[125I]IUdR, Piv2[125I]IUdR and [125I]IUdR (control) were prepared with labeling yields of 31-47% and radiochemical purities of >99% (HPLC). Both diesterified iodonucleoside tracers showed a nearly 100% resistance against degradation by thymidine phosphorylase. Ac2[125I]IUdR and Piv2[125I]IUdR were specifically integrated into the DNA of all tested tumor cell lines but to a less extend than the control [125I]IUdR. In mice, 24 h after i.p. injection, brain radioactivity uptakes were in the following order Piv2[125I]IUdR>Ac2[125I]IUdR>[125I]IUdR. For Ac2[125I]IUdR we detected lower amounts of radioactivities in the thyroid and stomach, suggesting a higher stability toward deiodination. In mice bearing unilateral graft-induced brain tumors, the uptake ratios of tumor-bearing to healthy hemisphere were 51, 68 and 6 for [125I]IUdR, Ac2[125I]IUdR and Piv2[125I]IUdR, respectively. Esterifications of both deoxyribosyl hydroxyl groups of the tumor tracer IUdR lead to advantageous properties regarding uptake into brain tumor tissue and metabolic stability.

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0102397PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100890PMC
November 2015
13 Reads

Publication Analysis

Top Keywords

ac2[125i]iudr piv2[125i]iudr
12
thymidine phosphorylase
8
brain tumors
8
tumor tissue
8
cell lines
8
uptake brain
8
brain tumor
8
brain
5
tumor
5
ac2[125i]iudr
5
integrated dna
4
tracer determined
4
ratios tumor-bearing
4
integration tracer
4
piv2[125i]iudr integrated
4
lines gl261
4
phosphorylase ac2[125i]iudr
4
uptake ratios
4
thyroid stomach
4
gl261 crl2397
4

References

(Supplied by CrossRef)
3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET
KJ Langen et al.
J Nucl Med 1997
18F-Fluoro-L-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors
AH Jacobs et al.
J Nucl Med 2005
Imaging Brain Tumor Proliferative Activity with [124I]Iododeoxyuridine
RG Blasberg et al.
Cancer Res 2000
Deoxyribonucleic acid metabolism in vivo: I. cell proliferation and death as measured by incorporation and elimination of iododeoxyuridine
WL Hughes et al.
Fed Proc 1964
Rationale of 5-125I-Iodo-4′-Thio-2′-Deoxyuridine as a Potential Iodinated Proliferation Marker
J Toyohara et al.
J Nucl Med 2002
Studies on the chemotherapy of experimental brain tumors: development of an experimental model
JI Ausman et al.
Cancer Res 1970

Similar Publications